Date | Title | Description | |
---|---|---|---|
10 May 2023 | On P&L | The Company releases the first quarter 2023 financial results presentation | Download |
10 May 2023 | On P&L | The Company releases the press release related to the first quarter 2023 financial results | Download |
25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download |
21 Feb 2023 | On business and financial situation | The Company releases the full year 2022 financial results presentation. | Download |
21 Feb 2023 | On business and financial situation | The Company releases the press release related to the full year 2022 financial results. | Download |
Pages
Date | Title | Description | |
---|---|---|---|
30 Jun 2022 | Other relevant information | The Company informs about the dividends payment | Download |
16 Jun 2022 | Other relevant information | The Company has agreed to execute the capital reduction approved by the 2022 Ordinary General Meeting to amortize the shares acquired in the framework of the own shares repurchase programs | Download |
14 Jun 2022 | Announcement of general shareholders’ meeting | ROVI releases the information related to its General Shareholders Meeting | Download |
11 May 2022 | On business and financial situation | The Company releases the press release related to the first quarter 2022 financial result | Download |
11 May 2022 | On business and financial situation | The Company releases the first quarter 2022 financial results presentation | Download |
Pages
Date | Title | Description | |
---|---|---|---|
03 Jul 2012 | Información sobre dividendos | Download | |
13 Jun 2012 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download | |
26 Apr 2012 | Información sobre resultados (2) | Download | |
26 Apr 2012 | Información sobre resultados | Download | |
26 Apr 2012 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download |